HK1245664B - Polypeptides to treat skin conditions associated with overproduction of sebum - Google Patents

Polypeptides to treat skin conditions associated with overproduction of sebum Download PDF

Info

Publication number
HK1245664B
HK1245664B HK18105412.9A HK18105412A HK1245664B HK 1245664 B HK1245664 B HK 1245664B HK 18105412 A HK18105412 A HK 18105412A HK 1245664 B HK1245664 B HK 1245664B
Authority
HK
Hong Kong
Prior art keywords
seq
amino acid
acid sequence
polypeptide
composition
Prior art date
Application number
HK18105412.9A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1245664A1 (en
Inventor
Changiz Taghibiglou
Yu Tian Wang
Original Assignee
Changiz Taghibiglou
Yu Tian Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changiz Taghibiglou, Yu Tian Wang filed Critical Changiz Taghibiglou
Publication of HK1245664A1 publication Critical patent/HK1245664A1/en
Publication of HK1245664B publication Critical patent/HK1245664B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK18105412.9A 2015-05-29 2016-05-27 Polypeptides to treat skin conditions associated with overproduction of sebum HK1245664B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562168374P 2015-05-29 2015-05-29
US62/168,374 2015-05-29
PCT/CA2016/050605 WO2016191864A1 (en) 2015-05-29 2016-05-27 Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum

Publications (2)

Publication Number Publication Date
HK1245664A1 HK1245664A1 (en) 2018-08-31
HK1245664B true HK1245664B (en) 2020-06-26

Family

ID=57439738

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18105412.9A HK1245664B (en) 2015-05-29 2016-05-27 Polypeptides to treat skin conditions associated with overproduction of sebum

Country Status (7)

Country Link
US (1) US11117939B2 (enExample)
EP (1) EP3307317B1 (enExample)
JP (1) JP6853239B2 (enExample)
KR (1) KR20180012833A (enExample)
CN (1) CN107921125B (enExample)
HK (1) HK1245664B (enExample)
WO (1) WO2016191864A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107325157B (zh) * 2017-08-07 2020-06-26 温州千瑞生物科技有限公司 调节皮脂分泌的肽以及包含其的化妆品
KR102268921B1 (ko) * 2019-12-10 2021-06-23 강원대학교산학협력단 p53을 활성화하는 펩타이드를 포함하는 조성물
KR102084163B1 (ko) * 2019-12-27 2020-05-15 주식회사 인투앱 프로피오니박테리움 아크네스 균으로부터 유래한 지방산 분해 효소에 특이적으로 결합하는 신규한 항체 및 이의 용도
EP4215178A1 (en) 2020-09-11 2023-07-26 Chemyunion Ltda Composition, use of the composition, cosmetic method and method for modulating the production of sebum
CN117003829A (zh) * 2023-07-24 2023-11-07 成都凯捷多肽科技有限公司 一种控油多肽化合物、制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007289063A (ja) * 2006-04-25 2007-11-08 Shiseido Co Ltd しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法
CA2677264C (en) * 2007-02-02 2021-11-30 Baylor College Of Medicine Compositions and methods for the treatment of metabolic disorders
WO2009121176A1 (en) * 2008-03-31 2009-10-08 The University Of British Columbia Insulin-induced gene (insig) peptide compositions and methods for cytoprotection
ES2601827T3 (es) 2009-02-24 2017-02-16 Arava Bio-Tech Ltd. Agentes antagonistas de visfatina para el tratamiento del acné y de otras afecciones
JP2011225455A (ja) * 2010-04-15 2011-11-10 Kao Corp Ｓｒｅｂｐ抑制剤
JP5353848B2 (ja) * 2010-09-24 2013-11-27 株式会社アドヴィックス 車両用ブレーキ装置
CA2850836A1 (en) * 2011-10-15 2013-04-18 Genentech, Inc. Methods of using scd1 antagonists
KR101910419B1 (ko) * 2012-02-10 2018-10-23 애경산업(주) 피지생성 억제용 화장료 조성물
JP5947061B2 (ja) * 2012-02-29 2016-07-06 花王株式会社 Ｓｒｅｂｐ１抑制剤
KR101528770B1 (ko) * 2013-06-13 2015-06-15 코스맥스 주식회사 사과 유래 폴리페놀을 함유하는 피지분비 완화 및 여드름 증상 개선용 화장료 조성물

Also Published As

Publication number Publication date
CN107921125B (zh) 2021-06-08
JP2018517767A (ja) 2018-07-05
KR20180012833A (ko) 2018-02-06
WO2016191864A1 (en) 2016-12-08
EP3307317B1 (en) 2019-09-04
EP3307317A1 (en) 2018-04-18
EP3307317A4 (en) 2019-01-16
US20180305419A1 (en) 2018-10-25
CN107921125A (zh) 2018-04-17
US11117939B2 (en) 2021-09-14
JP6853239B2 (ja) 2021-03-31

Similar Documents

Publication Publication Date Title
EP3307317B1 (en) Polypeptides to treat skin conditions associated with overproduction of sebum
HK1245664A1 (en) Polypeptides to treat skin conditions associated with overproduction of sebum
KR101503152B1 (ko) 미토콘드리아 타겟팅 펩타이드
KR20100039861A (ko) 펩티드 티로시나제 억제제 및 그의 용도
JP2021506899A (ja) ボツリヌス毒素細胞結合ドメインポリペプチドおよび線維症関連障害の処置のための使用方法
CN113396157A (zh) 具有降低的胰岛素受体结合亲和力的胰岛素类似物
JP6480921B2 (ja) コレステロール誘発性ミトコンドリア機能不全を治療するための芳香族カチオン性ペプチドの使用
CA2777628C (en) Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods
US8663630B2 (en) Promotion of peroxisomal catalase function in cells
CN107530398B (zh) 抗微生物肽
WO2008050133A2 (en) Inhibition of beta-amyloid aggregation
US11819537B2 (en) Preventive or therapeutic method for inflammatory skin disease
US9334314B2 (en) Peptide compounds derived from melanotransferrin and uses thereof
JP2015514134A (ja) 芳香族カチオン性ペプチド及びその使用
JP2006515168A5 (enExample)
CA3022763A1 (en) Novel peptides and peptidomimetics
Ehtesham et al. Functional studies on a Novel Engineered peptide derived from C-Terminal of human endostatin
HK1174944B (en) Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods